VKTX I feel like this is the week for VK2809 results. It would make sense based on the enrolment date of the last patient in the Phase 2B study; 4-5 weeks after last follow-up visit is *more than enough* to analyze and report the results of a small clinical trial.
VK2809 results were previously do or die. I can't believe I'm saying this given my excitement about NASH results, but they've become almost a sideshow vs VK2735. Downside is limited even if VK2809 is a bust (unlikely). Holding through binary!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.